24. November 2020
Transglutaminase-Newsletter | November 2020
Dear Transglutaminase researchers,
The year 2020 threw many hurdles into everyones way. This was certainly challenging for all of us. Remarkably, throughout the pandemia the Zedira team was able to sustain our delivery chain and provided you, our customers, with our well-known high quality transglutaminase products in a timely manner.
This is a great time to thank all of our customers, suppliers, and employees for their support. Zedira will work at its best to assist your R&D efforts with products and individual services.
But the year is not over yet!
We start our end of year sprint and send our Zedira calculator with all orders until December 31st, 2020. Find below a selection of our top sellers to support your work in the upcomming year.
Stay healthy, sincerely yours,
On behalf of the entire Zedira team
Martin Hils and Ralf Pasternack
Please have a look on selected products from our broad range of transglutaminase specialty reagents.
You can find more of them and additional information at zedira.com or just by contacting us (contact@zedira.com).
Microbial Transglutaminase, MTG
Neuronal Transglutaminase, TG6
Now part of the European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders (Al-Toma et al., 2019).
Tissue Transglutaminase, TG2
Coagulation Factor XIII, FXIII
End of year sprint!
Transglutaminase-Newsletter | November 2020 | Get your free Zedira CalculatorFor all orders until December 31st, 2020! |
Dear Transglutaminase researchers,
The year 2020 threw many hurdles into everyones way. This was certainly challenging for all of us. Remarkably, throughout the pandemia the Zedira team was able to sustain our delivery chain and provided you, our customers, with our well-known high quality transglutaminase products in a timely manner.
This is a great time to thank all of our customers, suppliers, and employees for their support. Zedira will work at its best to assist your R&D efforts with products and individual services.
But the year is not over yet!
We start our end of year sprint and send our Zedira calculator with all orders until December 31st, 2020. Find below a selection of our top sellers to support your work in the upcomming year.
Stay healthy, sincerely yours,
On behalf of the entire Zedira team
Martin Hils and Ralf Pasternack
Please have a look on selected products from our broad range of transglutaminase specialty reagents.
You can find more of them and additional information at zedira.com or just by contacting us (contact@zedira.com).
Microbial Transglutaminase, MTG
| Art. No. | Name | Unit | Price |
| T001 | Microbial (bacterial) transglutaminase (MTG, recombinantly produced in E. coli, gene derived from Streptomyces mobaraensis) | 25 U 250 U 10x 25 U 500 U 20x 25 U | 270 € 2140 € 2140 € 3750 € 3750 € |
| Z009 Application: | ZediXclusive Microbial Transglutaminase Assay Kit Determination of microbial transglutaminase activity | 1 Kit | 310 € |
| A145 Immunogen: | Polyclonal antibody to microbial transglutaminase Microbial transglutaminase (T001), raised in mouse | 200 µg | 365 € |
| C102 Application: | MTG-Blocker Inhibition of microbial transglutaminase, IC50 ~ 125 μM | 10 mg 25 mg | 210 € 385 € |
Neuronal Transglutaminase, TG6
Now part of the European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders (Al-Toma et al., 2019).
| Art. No. | Name | Unit | Price |
| E103 Application: | ZediXclusive TG6-ab ELISA (IgA) ELISA for the determination of autoantibodies (IgA) against human Transglutaminase 6 | 1 kit/ 96 wells | 520 € |
| E104 Application: | ZediXclusive TG6-ab ELISA (IgG) ELISA for the determination of autoantibodies (IgG) against human Transglutaminase 6 | 1 kit/ 96 wells | 520 € |
| T021 | Human neuronal transglutaminase (TG6, recombinantly produced in insect cells) | 250 µg | 475 € |
Tissue Transglutaminase, TG2
| Art. No. | Name | Unit | Price |
| T022 | Human tissue transglutaminase (hTG2, recombinantly produced in insect cells) | 250 µg 1 mg | 370 € 1100 € |
| M003 Application: | Tissue Transglutaminase Pico-Assay Kit Determination of tissue transglutaminase activity | 1 Kit | 395 € |
| A028 Format: | FITC-labeled polyclonal antibody to human TG2 A014 purified via affinity chromatography on protein A, followed by FITC-labeling | 200 µg | 395 € |
| Z006 Synonym: Application: | Z-DON-Val-Pro-Leu-OMe, „Z-DON“ Z-DON Irreversible inhibitor of tissue transglutaminase | 10 mg | 385 € |
Coagulation Factor XIII, FXIII
| Art. No. | Name | Unit | Price |
| T027 | Human blood coagulation Factor XIII-A2 (hFXIII, A subunit, recombinantly produced in insect cells) | 200 µg | 370 € |
| T070 | Human Factor XIIIa, Thrombin activated (hFXIIIa, recombinantly produced in insect cells) | 200 µg | 520 € |
| F001 Application: | FXIII-Assay Kit Ready to use, contains FXIII-Assay Substance (A101) and thrombin Fluorescent measurement of transglutaminase activity, optimized for FXIII | 1 Kit | 575 € |
| T101 Application: | 1,3,4,5-Tetramethyl-2-[(2-oxopropyl)thio]imidazolium chloride Inhibitor for transglutaminase | 10 mg | 480 € |
| A108 Synonym: Application: | Ac-(D)-Asp-MA-Nle-Nle-Leu-Pro-Trp-Pro-OH ZED1301 Site specific irreversible inhibitor of plasma transglutaminase | 5 mg | 480 € |
Successful ISO9001:2015 recertification 
Besuch des Bundesministers für Wirtschaft und Klimaschutz Dr. Robert Habeck bei der Zedira 
Discover Our New Catalogue Edition and Dive into the World of Transglutaminases! 
Successful ISO9001:2015 recertification 
Dr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease 
Dr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie 
Reversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis 
Transcriptomic analysis of the efficacy of TG2-inhibitor trials and human intestinal organoids modelling Celiac disease pathogenesis 
Transglutaminase antibodies and neurological manifestations of gluten sensitivity 
Design of Oral FXIIIa Blockers as Safer Anticoagulants Mission Impossible? 
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering 
Tridegin as FXIIIa inhibitor 
Microbial transglutaminase: from discovery to market 
Tissue transglutaminase inhibitors 
Tissue transglutaminase in Alzheimers Disease 
Factor XIIIa: novel target for anticoagulation? 
Microbial transglutaminase for site-specific protein conjugation